Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
More news for Friday, May 19
By
Kimberly Bonvissuto
May 19, 2023
Western diet ID’d as risk factor for Alzheimer’s disease … Sense of purpose promotes cognitive resilience into old age … Genetic links seen for HDL cholesterol, systolic BP with Alzheimer’s disease
Medicare spending would increase $2.0 to $5.1 billion with lecanemab
May 18, 2023
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
High school inventors create virtual friend to help seniors with loneliness
By
Christine Birkner
May 18, 2023
Technology can combat loneliness. High school inventors created a new virtual friend to keep older adults company and loneliness at bay.
Proposed bill would ‘destroy dementia training,’ advocates say
By
Kimberly Bonvissuto
May 18, 2023
A proposed bill before the Illinois Legislature would “destroy dementia training” for healthcare providers by reducing education requirements, according to dementia care advocates.
More news for Thursday, May 18
By
Kimberly Bonvissuto
May 18, 2023
Provider brings ‘magic tables’ to all CCRCs … NIH awards $2.3M to study link between COVID-19, cognitive decline … 5 plead guilty in fraudulent nursing diploma scheme
Genetic links seen for HDL cholesterol, systolic BP with Alzheimer’s disease
May 17, 2023
Genetically determined high-density lipoprotein cholesterol and systolic blood pressure were linked to increased odds of Alzheimer’s disease.
More news for Wednesday, May 17
By
Kimberly Bonvissuto
May 17, 2023
Pat Mulloy, former senior living CEO and Argentum board president, named Louisville, KY, economic development head … Scientists use AI to ID drug targets in search for Alzheimer’s cure … Rate of...
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.
A permanent commission in New Jersey will be dedicated to evaluating current systems and making recommendations to improve care for people living with dementia and their caregivers.